Literature DB >> 12500030

Pressor response to intravenous tyramine is a marker of cardiac, but not vascular, adrenergic function.

Janice V Meck1, David S Martin, Dominick S D'Aunno, Wendy W Waters.   

Abstract

Intravenous injections of the indirect sympathetic amine, tyramine, are used as a test of peripheral adrenergic function. The authors measured the time course of increases in ejection fraction, heart rate, systolic and diastolic pressure, popliteal artery flow, and greater saphenous vein diameter before and after an injection of 4.0 mg/m(2) body surface area of tyramine in normal human subjects. The tyramine caused moderate, significant increases in systolic pressure and significant decreases in total peripheral resistance. The earliest changes were a 30% increase in ejection fraction and a 16% increase in systolic pressure, followed by a 60% increase in popliteal artery flow and a later 11% increase in greater saphenous vein diameter. There were no changes in diastolic pressure or heart rate. These results suggest that pressor responses during tyramine injections are primarily due to an inotropic response that increases cardiac output and pressure and causes a reflex decrease in vascular resistance. Thus, tyramine pressor tests are a measure of cardiac, but not vascular, sympathetic function.

Entities:  

Keywords:  NASA Center JSC; NASA Discipline Cardiopulmonary

Mesh:

Substances:

Year:  2003        PMID: 12500030     DOI: 10.1097/00005344-200301000-00016

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  6 in total

1.  Dopamine contamination of infused tyramine.

Authors:  Courtney Holmes; Jeffrey Moak; Basil Eldadah; Ella Zimmerly; Yehonatan Sharabi; David S Goldstein
Journal:  Clin Chem       Date:  2005-07-21       Impact factor: 8.327

2.  Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension.

Authors:  Yehonatan Sharabi; Richard Imrich; Courtney Holmes; Sandra Pechnik; David S Goldstein
Journal:  Mov Disord       Date:  2008-09-15       Impact factor: 10.338

3.  The trace amine theory of spontaneous hypertension as induced by classic monoamine oxidase inhibitors.

Authors:  Vincent Van den Eynde
Journal:  J Neural Transm (Vienna)       Date:  2021-08-09       Impact factor: 3.575

4.  Functional effects of cardiac sympathetic denervation in neurogenic orthostatic hypotension.

Authors:  Richard Imrich; Basil A Eldadah; Oladi Bentho; Sandra Pechnik; Yehonatan Sharabi; Courtney Holmes; Ehud Grossman; David S Goldstein
Journal:  Parkinsonism Relat Disord       Date:  2008-05-29       Impact factor: 4.891

Review 5.  A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths.

Authors:  Peter Kenneth Gillman
Journal:  J Neural Transm (Vienna)       Date:  2018-09-25       Impact factor: 3.575

6.  Synthesis and Biological Evaluation of Pyrimidine-oxazolidin-2-arylimino Hybrid Molecules as Antibacterial Agents.

Authors:  Roberto Romeo; Maria A Chiacchio; Agata Campisi; Giulia Monciino; Lucia Veltri; Daniela Iannazzo; Gianluigi Broggini; Salvatore V Giofrè
Journal:  Molecules       Date:  2018-07-17       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.